HTL Biotechnology inaugurates a new production line dedicated to sterile Hyaluronic Acid
As part of National Biomanufacturing Day 2025, HTL Biotechnology inaugurates a new production line dedicated to Hyaluronic Acid.
Hear from experts on why the quality and origin of raw materials are important for the efficacy and safety of treatments in aesthetic medicine:
In this first interview, Dr. Abs Settipalli, an aesthetic medicine and biotechnology expert, talks about various topics concerning raw materials in aesthetic medicine such as:
Next we have Dr. Tingsong Lim, a renowned aesthetic doctor from Malaysia, who talks about:
Finally, Dr. Nabila Azib, a leading aesthetic physician from Morocco, shares her valuable insights on:
With strong expertise in the field, HTL Biotechnology is a leader in the development and manufacturing of premium quality biopolymers for medical aesthetics
Click on the link or contact our team to learn more about our biopolymers.
Osteoarthritis is a degenerative joint disorder, often leading to chronic pain and reduced mobility as cartilage deteriorates over time.
Due to its viscoelastic properties, Hyaluronic acid (HA), a naturally occurring molecule in the body and a major component of the extracellular matrix, is an ideal candidate for addressing these degenerative processes of joint diseases. Recognized for its lubricating properties, HA is also shaping the management of osteoarthritis and rheumatologic diseases through its multi-faceted therapeutic potential.